Prof. Thomas Kiernan

Biography

Professor Kiernan is a graduate of University College Dublin (M.B. B.Ch. B.A.O. 1999). He completed his medical residency and early cardiology training in Ireland and the USA. He was awarded his MD Thesis (Cellular therapies for Cardiovascular Disease) from Mayo Clinic, Minnesota USA. He then pursued a fellowship in Interventional and Structural Cardiology in Massachusetts General Hospital/Harvard Medical School, Boston USA (2007-2009). He took up post of Consultant Cardiologist in Cork University Hospital, 2009 and moved to University Hospital Limerick 2012 where he was promoted to Clinical Lead for Cardiology, UL Hospitals Group and Associate Professor of Medicine Graduate Entry Medical School, University of Limerick. Since in post, he has spearheaded the introduction of 24/7 ST-Elevation Myocardial Infarction (STEMI) service for the region as well as multi-disciplinary heart team meetings, structural heart disease programme for the region and development of a cardiology research team which partake in both national and international clinical trials and research projects.

TRAINING:

Professor Tom Kiernan is a Consultant Interventional Cardiologist and the Clinical Director at Beacon Limerick. Prof Kiernan is a graduate of University College Dublin. He completed his medical residency and early cardiology training in Ireland and the USA. He completed interventional cardiology research and clinical interventional fellowship at Mayo Clinic, Rochester, Minnesota and Massachusetts General Hospital/Harvard Medical School.

EXPERIENCE:

Professor Kiernan was appointed Academic Lead for Cardiology, UL Hospitals Group and Associate Professor of Medicine Graduate Entry Medical School, University of Limerick in 2012. Since in post, he has spearheaded the introduction of a 24/7 ST-Elevation Myocardial Infarction (STEMI) service for the region. He currently serves as the National Lead for PCI as part of the Clinical Advisory Group and as Council Member of the Irish Cardiac Society.

Peer Reviewed Journals

2022

Peak troponin T in STEMI: a predictor of all-cause mortality and left ventricular function

Khullar, N;Buckley, AJ;O'Connor, C;Ibrahim, A;Ibrahim, A;Ahern, C;Cahill, C;Arnous, S;Kiernan, TJ (2022) Peak troponin T in STEMI: a predictor of all-cause mortality and left ventricular function. LONDON : BMJ PUBLISHING GROUP Open Heart

Biography

Publications

Peer Reviewed Journals

Peak troponin T in STEMI: a predictor of all-cause mortality and left ventricular function

Activation of PPCI team in the octogenarian and nonagenarians population: real-world single-centre experience

Interhospital and interindividual variability in secondary prevention: a comparison of outpatients with a history of chronic coronary syndrome versus outpatients with a history of acute coronary syndrome (the iASPIRE Study)

Outcomes of nurse-led clinic for patients treated with percutaneous coronary intervention: A retrospective analysis

Performing diagnostic radial access coronary angiography on uninterrupted direct oral anticoagulant therapy: a prospective analysis

Anchor-balloon technique to facilitate stent delivery via the GuideLiner catheter in percutaneous coronary intervention

Revascularisation of left main stem disease: a prospective analysis of modern practice and outcomes in a non-surgical centre

Significance of High-Sensitivity Troponin T After Elective External Direct Current Cardioversion for Atrial Fibrillation or Atrial Flutter

Circadian and seasonal variations in patients with acute STEMI: A retrospective, single PPCI center study

Left distal trans-radial access facilitates earlier discharge post-coronary angiography

A Young Male with Severe Myocarditis and Skeletal Muscle Myositis

Erectile Dysfunction and Ischaemic Heart Disease

Spontaneous coronary artery dissection, challenges of diagnosis and management

Contemporary management of prosthetic valve endocarditis: principals and future outlook

Principles of Diagnosis for, and Interventional Treatment of, Critical Leg Ischemia

Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality.

Books

Book Chapters

Edited Books

Other Journals

Conference Publications

Conference Contributions

Published Reports

Editorials

Book Reviews

Other Publications

Diagnosing, fast and slow

ICD Implantation As Part Of Myocarditis Management In Young Adult With Suspicion Of Underlying Genetic Cardiac Disease

High-sensitivity troponin assays: development and utility in a modern health-care system

Patent foramen ovale and cryptogenic stroke: contemporary evidence and treatment

PROGNOSTIC VALUE OF HIGH-SENSITIVITY CARDIAC TROPONIN T IN PATIENTS WITH ST-SEGMENT-ELEVATION MYOCARDIAL INFARCTION

Does a nurse-led cardiac rehabilitation inpatient education following percutaneous coronary intervention reduce the rate of 28 day hospital re-admission

Letter in reply to &quot;How to manage a spontaneous coronary artery dissection: reconsidering diagnosis and therapy&apos;

The genetic basis of antiplatelet and anticoagulant therapy: A pharmacogenetic review of newer antiplatelets (clopidogrel, prasugrel and ticagrelor) and anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban)

Fractional flow reserve in 2017: current data and everyday practice

PERIPHERAL ENDOTHELIAL FUNCTION ASSESSMENT OF PATIENTS ON TICAGRELOR VERSUS CLOPIDOGREL WHO HAVE UNDERGONE PERCUTANEOUS CORONARY INTERVENTION: A RANDOMIZED, CROSSOVER STUDY

Prevalence and determinants of restless leg syndrome among heart failure patients

HIGH SENSITIVE TROPONIN T LEVELS FOLLOWING ELECTIVE EXTERNAL DIRECT CURRENT CARDIOVERSION FOR ATRIAL FIBRILLATION AND ATRIAL FLUTTER

CLINICAL AND ECONOMIC OUTCOMES OF FRACTIONAL FLOW RESERVE GUIDED PCI IN CONTEMPORARY PRACTICE

Heart rate in heart failure - are we in control? An audit on heart rate control in heart failure patients attending the heart failure units

SCREENING FOR DIABETES AND PRE-DIABETES IN PATIENTS ADMITTED WITH ACUTE CORONARY SYNDROME TO THE UNIVERSITY HOSPITAL LIMERICK

Investigational new drugs for the treatment of acute coronary syndrome

Pulmonary Valve Papillary Fibroelastoma: A Rare Tumor and Rare Location

In the Current Era of ST Elevation Myocardial Infarction Treatment: What Patients are Not Reperfused?

In the current era of ST-elevation myocardial infarction treatment, what patients are not reperfused? An observational analysis

Retrospective analysis of LDL control in very high risk patients with coronary artery disease requiring percutaneous coronary intervention (PCI)

The Association Between Timeliness of Reperfusion Therapy, Left Ventricular Function and In-Patient Mortality of Stemi Patients Presenting Out of Hours vs Working Hours

Medical therapy for critical limb ischemia and the diabetic foot: an update

The Association Between Timeliness of Reperfusion Therapy, Left Ventricular Function and In-Patient Mortality of STEMI Patients Presenting out of Hours vs Working Hours

The association between timeliness of reperfusion therapy, left ventricular function and in-patient mortality of STEMI patients presenting out of hours vs. working hours

Retrospective Analysis on Lipid Profiles in Very High Risk Patients Requiring PCI. Are We Adhering to the Guidelines?

Letter in reply to "How to manage a spontaneous coronary artery dissection: reconsidering diagnosis and therapy'